Ocular Therapeutix OCUL Enterprise value

Enterprise value at other companies

Regeneron PharmaceuticalsREGN

$65.61B+15.0%

EyePoint, Inc.EYPT

$1.11B+90.1%

KLR

Kalaris TherapeuticsKLRS

$99.28M—

Bausch + LombBLCO

$10.6B+18.6%

HRO

HarrowHROW

$1.53B+13.8%

Tarsus Pharmaceuticals, Inc.TARS

$2.59B+51.2%

FAQ

What is Ocular Therapeutix's enterprise value?

Ocular Therapeutix (OCUL) reported enterprise value of $1.26B in Q1 2026.

How has Ocular Therapeutix's enterprise value changed year-over-year?

Ocular Therapeutix's enterprise value increased by 40.8% year-over-year, from $892.18M to $1.26B.

What is the long-term trend for Ocular Therapeutix's enterprise value?

Over 5 years (2020 to 2025), Ocular Therapeutix's enterprise value has grown at a 6.8% compound annual growth rate (CAGR), from $1.38B to $1.93B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.